3.3.1. Evaluation of the Frequencies and Serum Levels of Anti-Zta and Anti-LMP1 in Oropharyngeal Cancer Patients Depending on the Grading (G1–G3) and TNM Classification. This evidence concerns the gene PDLIM7 and oropharynx cancer.